The 20mg combination vial which pairs BPC-157 with TB-500 (Thymosin Beta-4) offers a significantly lower cost per milligram and combines two of the most researched recovery peptides in a single reconstituted solution, making it especially efficient for injury recovery and tissue repair protocols when back in stock
BPC-157 is commonly studied in the context of tissue signaling, angiogenesis, gastric biology, nitric oxide modulation, and musculoskeletal tissue research in preclinical models
Rapid endothelial restoration and activation of the major collaterals (in addition, there are abundant anastomoses between individual vessels on both surfaces of the large intestine (Vukojevic et al., 2018
Since classic models are not combined, gastric/duodenal ulcer models (Selye and Szabo, 1973
When administered under medical supervision, BPC-157 and TB-500 peptide therapy is generally well tolerated
We are committed to helping our customers